The DOI matches its Crossref record; 27 of the 27 references it cites were found in a registry or an index.
Hydrogel-forming microneedles enhance transdermal delivery of metformin hydrochloride
Open accessAbstract
We investigated, for the first time, the potential for a hydrogel-forming microneedle (MN) patch to deliver the high-dose drug metformin HCl transdermally in a sustained manner. This may minimize some gastrointestinal side effects and small intestine absorption variations associated with oral delivery. Patches (two layers) were assembled from a lyophilised drug reservoir layer, with the MN layer made from aqueous blend of 20% w/w poly (methylvinylether- co -maleic acid) crosslinked by esterification with 7.5% w/w poly (ethylene glycol) 10,000 Da. >90% of metformin was recovered from homogeneous drug reservoirs. Drug reservoir dissolution time in PBS (pH 7.4) was <10 min. MN penetrated a validated skin model Parafilm® M consistently. Permeation of metformin HCl across dermatomed neonatal porcine skin in vitro was enhanced by using MN. The combined MN and metformin HCl reservoir patch (containing 75 mg or 50 mg metformin HCl, respectively) delivered 9.71 ± 2.22 mg and 10.04 ± 1.92 mg at 6 h, respectively, and 28.15 ± 2.37 mg and 23.25 ± 3.58 mg at 24 h, respectively.In comparison, 0.34 ± 0.39 mg and 0.85 ± 0.68 mg was delivered at 6 h, respectively, and 0.39 ± 0.39 mg and 1.01 ± 0.84 mg was delivered at 24 h, respectively, from a control set-up employing only the drug reservoirs. In vivo , metformin HCl was detected in rat plasma at 1 h post MN application at a concentration of 0.62 ± 0.51 μg/mL, increasing to 3.76 ± 2.58 μg/ml at 3 h. A maximal concentration of 3.77 ± 2.09 μg/ml was achieved at 24 h. C ss was 3.2 μg/mL. Metformin transdermal bioavailability using MNs was estimated as 30%.Hydrogel-forming MN are a promising technology that has demonstrated successful transdermal delivery of metformin HCl. Potential clearly exists for administration of other high-dose drugs using this system.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Role of AMP-Activated Protein Kinase in Mechanism of Metformin Action
Zhou, G., Myers, R., Li, Y., Chen, Y., Shen, X., Fenyk-Melody, J., Wu, M., Ventre, J., Doebber, T., Fujii, N., et al. (2001) · Journal of Clinical Investigation · doi:10.1172/jci13505 · Cited by 5,652
Cellular and molecular mechanisms of metformin: an overview
Viollet, B., Guigas, B., Garcia, N. S., Leclerc, J., Foretz, M., & Andreelli, F. (2012) · Clinical Science · doi:10.1042/cs20110386 · Cited by 1,720
Risk of fatal and nonfatal lactic acidosis with metformin use in type 2 diabetes mellitus
Salpeter, S. R., Greyber, E., Pasternak, G. A., & Salpeter (posthumous), E. E. (2010) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd002967.pub4 · Cited by 893
Singh, J. (2015) · Journal of Pharmacology and Pharmacotherapeutics · doi:10.4103/0976-500x.162004 · Cited by 893
Metformin and the gastrointestinal tract
McCreight, L. J., Bailey, C. J., & Pearson, E. R. (2016) · Diabetologia · doi:10.1007/s00125-015-3844-9 · Cited by 733 · cited 1×
“Metformin intolerance may relate to different mechanisms, including altered transport of serotonin or histamine, local metformin accumulation in enterocytes, increased bile acid exposure in the colon and altered gut microbiome [18,19].”
BackgroundHydrogel‐Forming Microneedle Arrays for Enhanced Transdermal Drug Delivery
Donnelly, R. F., Singh, T. R. R., Garland, M. J., Migalska, K., Majithiya, R., McCrudden, C. M., Kole, P. L., Mahmood, T. M. T., McCarthy, H. O., & Woolfson, A. D. (2012) · Advanced Functional Materials · doi:10.1002/adfm.201200864 · Cited by 727
Self-citationA proposed model membrane and test method for microneedle insertion studies
Larrañeta, E., Moore, J., Vicente-Pérez, E. M., González-Vázquez, P., Lutton, R., Woolfson, A. D., & Donnelly, R. F. (2014) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2014.05.042 · Cited by 603
Self-citationMetformin pathways: pharmacokinetics and pharmacodynamics
Gong, L., Goswami, S., Giacomini, K. M., Altman, R. B., & Klein, T. E. (2012) · Pharmacogenetics and Genomics · doi:10.1097/fpc.0b013e3283559b22 · Cited by 495
Viollet, B., Guigas, B., Leclerc, J., Hébrard, S., Lantier, L., Mounier, R., Andreelli, F., & Foretz, M. (2009) · Acta Physiologica · doi:10.1111/j.1748-1716.2009.01970.x · Cited by 486
Microneedles for intradermal and transdermal drug delivery
Tuan-Mahmood, T.-M., McCrudden, M. T. C., Torrisi, B. M., McAlister, E., Garland, M. J., Singh, T. R. R., & Donnelly, R. F. (2013) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2013.05.005 · Cited by 468
Self-citation
Cited by
Microneedles: A smart approach and increasing potential for transdermal drug delivery system
Waghule, T., Singhvi, G., Dubey, S. K., Pandey, M. M., Gupta, G., Singh, M., & Dua, K. (2019) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2018.10.078 · Cited by 1,260
Enhancement strategies for transdermal drug delivery systems: current trends and applications
Ramadon, D., McCrudden, M. T. C., Courtenay, A. J., & Donnelly, R. F. (2022) · Drug Delivery and Translational Research · doi:10.1007/s13346-021-00909-6 · Cited by 649
Self-citationEmerging Role of Hydrogels in Drug Delivery Systems, Tissue Engineering and Wound Management
Jacob, S., Nair, A. B., Shah, J., Sreeharsha, N., Gupta, S., & Shinu, P. (2021) · Pharmaceutics · doi:10.3390/pharmaceutics13030357 · Cited by 485
Hydrogel-based commercial products for biomedical applications: A review
Cascone, S., & Lamberti, G. (2020) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2019.118803 · Cited by 421
Microneedle for transdermal drug delivery: current trends and fabrication
Jung, J. H., & Jin, S. G. (2021) · Journal of Pharmaceutical Investigation · doi:10.1007/s40005-021-00512-4 · Cited by 416
Hydrogel‐Forming Microneedles: Current Advancements and Future Trends
Turner, J. G., White, L. R., Estrela, P., & Leese, H. S. (2021) · Macromolecular Bioscience · doi:10.1002/mabi.202000307 · Cited by 413
Hydrogel design strategies for drug delivery
Dreiss, C. A. (2020) · Current Opinion in Colloid & Interface Science · doi:10.1016/j.cocis.2020.02.001 · Cited by 356
Microneedle array systems for long-acting drug delivery
Vora, L. K., Moffatt, K., Tekko, I. A., Paredes, A. J., Volpe-Zanutto, F., Mishra, D., Peng, K., Raj Singh Thakur, R., & Donnelly, R. F. (2021) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2020.12.006 · Cited by 270
Self-citationTreatment strategies against diabetes: Success so far and challenges ahead.
Khursheed, R., Singh, S. K., Wadhwa, S., Kapoor, B., Gulati, M., Kumar, R., Ramanunny, A. K., Awasthi, A., & Dua, K. (2019) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2019.172625 · Cited by 239
Advances in microneedle-based transdermal delivery for drugs and peptides
Aich, K., Singh, T., & Dang, S. (2022) · Drug Delivery and Translational Research · doi:10.1007/s13346-021-01056-8 · Cited by 65
“[42] have performed a study on hydrogelforming microneedles for transdermal administration of metformin to decrease oral-related gastrointestinal side effects.”
BackgroundIncorporating surfactants into PCL microneedles for sustained release of a hydrophilic model drug
Bader, N., & Abu Ammar, A. (2024) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2024.123826 · Cited by 27
Metadata
- Authors
- Migdadi, E. M., Courtenay, A. J., Tekko, I. A., McCrudden, M. T. C., Kearney, M.-C., McAlister, E., McCarthy, H. O., & Donnelly, R. F.
- Venue
- Journal of Controlled Release
- Publisher
- Elsevier BV
- Published
- 2018-09
- Volume
- 285
- Pages
- 142-151
- ISSN
- 0168-3659 (ISSN-L)
- OpenAlex
- W2855666604
- Cited by
- 279
- References
- 27
- FWCI
- 9.95
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.